Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)
Clinical trial NCT00091572 · COMPLETED
Trial details
- NCT number
- NCT00091572
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-20
- Primary completion
- 2007-12-31
- Enrollment
- 859
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.